##gff-version 3
Q9NYK1	UniProtKB	Signal peptide	1	26	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Chain	27	1049	.	.	.	ID=PRO_0000034733;Note=Toll-like receptor 7	
Q9NYK1	UniProtKB	Topological domain	27	839	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Transmembrane	840	860	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Topological domain	861	1049	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Repeat	43	64	.	.	.	Note=LRR 1	
Q9NYK1	UniProtKB	Repeat	65	87	.	.	.	Note=LRR 2	
Q9NYK1	UniProtKB	Repeat	110	126	.	.	.	Note=LRR 3	
Q9NYK1	UniProtKB	Repeat	127	149	.	.	.	Note=LRR 4	
Q9NYK1	UniProtKB	Repeat	151	170	.	.	.	Note=LRR 5	
Q9NYK1	UniProtKB	Repeat	171	195	.	.	.	Note=LRR 6	
Q9NYK1	UniProtKB	Repeat	203	226	.	.	.	Note=LRR 7	
Q9NYK1	UniProtKB	Repeat	228	247	.	.	.	Note=LRR 8	
Q9NYK1	UniProtKB	Repeat	248	275	.	.	.	Note=LRR 9	
Q9NYK1	UniProtKB	Repeat	289	312	.	.	.	Note=LRR 10	
Q9NYK1	UniProtKB	Repeat	314	337	.	.	.	Note=LRR 11	
Q9NYK1	UniProtKB	Repeat	339	368	.	.	.	Note=LRR 12	
Q9NYK1	UniProtKB	Repeat	369	392	.	.	.	Note=LRR 13	
Q9NYK1	UniProtKB	Repeat	396	419	.	.	.	Note=LRR 14	
Q9NYK1	UniProtKB	Repeat	421	443	.	.	.	Note=LRR 15	
Q9NYK1	UniProtKB	Repeat	492	515	.	.	.	Note=LRR 16	
Q9NYK1	UniProtKB	Repeat	516	540	.	.	.	Note=LRR 17	
Q9NYK1	UniProtKB	Repeat	541	564	.	.	.	Note=LRR 18	
Q9NYK1	UniProtKB	Repeat	566	588	.	.	.	Note=LRR 19	
Q9NYK1	UniProtKB	Repeat	595	618	.	.	.	Note=LRR 20	
Q9NYK1	UniProtKB	Repeat	619	644	.	.	.	Note=LRR 21	
Q9NYK1	UniProtKB	Repeat	649	672	.	.	.	Note=LRR 22	
Q9NYK1	UniProtKB	Repeat	674	697	.	.	.	Note=LRR 23	
Q9NYK1	UniProtKB	Repeat	698	721	.	.	.	Note=LRR 24	
Q9NYK1	UniProtKB	Repeat	723	745	.	.	.	Note=LRR 25	
Q9NYK1	UniProtKB	Repeat	746	769	.	.	.	Note=LRR 26	
Q9NYK1	UniProtKB	Repeat	772	795	.	.	.	Note=LRR 27	
Q9NYK1	UniProtKB	Domain	889	1033	.	.	.	Note=TIR;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00204	
Q9NYK1	UniProtKB	Glycosylation	66	66	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	69	69	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	167	167	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	202	202	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	215	215	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	361	361	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	413	413	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	488	488	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	523	523	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	534	534	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	590	590	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	679	679	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	720	720	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Glycosylation	799	799	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NYK1	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_034554;Note=Q->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19924287;Dbxref=dbSNP:rs179008,PMID:19924287	
Q9NYK1	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_087534;Note=In SLEB17%3B increased NFKB1 activation after stimulation with guanosine and ssRNA. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:35477763;Dbxref=PMID:35477763	
Q9NYK1	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_087535;Note=In SLEB17%3B increased NFKB1 activation after stimulation with cGMP. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:35477763;Dbxref=PMID:35477763	
Q9NYK1	UniProtKB	Natural variant	448	448	.	.	.	ID=VAR_024665;Note=A->V;Dbxref=dbSNP:rs5743781	
Q9NYK1	UniProtKB	Natural variant	507	507	.	.	.	ID=VAR_087536;Note=In SLEB17%3B increased NFKB1 activation after stimulation with cGMP. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:35477763;Dbxref=PMID:35477763	
Q9NYK1	UniProtKB	Natural variant	795	795	.	.	.	ID=VAR_084629;Note=In IMD74%3B no enhanced expression after stimulation by imiquimod%3B defective up-regulation of type IIFN-related genes%3B decreased expression of IFNG. V->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:32706371;Dbxref=dbSNP:rs200553089,PMID:32706371	
Q9NYK1	UniProtKB	Sequence conflict	725	725	.	.	.	Note=L->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9NYK1	UniProtKB	Sequence conflict	738	738	.	.	.	Note=L->P;Ontology_term=ECO:0000305;evidence=ECO:0000305